000 04314nam a22003975i 4500
001 81567
003 ES-MaUEC
005 20240611040138.0
007 cr nn 008mamaa
008 150523s2015 gw | s |||| 0|eng d
020 _a9783662463444
024 7 _a10.1007/978-3-662-46344-4
_2doi
050 4 _aRC346
_b.B44 2015 EB
082 0 4 _a612.8
245 1 0 _aBehavioral Neurobiology of Huntington's Disease and Parkinson's Disease
_cedited by Hoa Huu Phuc Nguyen, M. Angela Cenci.
264 1 _aBerlin, Heidelberg
_bSpringer
_c2015
300 _a1 recurso en línea (XIII, 397 páginas)
_b95 ilustraciones, 25 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aCurrent Topics in Behavioral Neurosciences
_x1866-3370
_v22
505 0 _aClinical Aspects of Huntingtonâ€{u3804}isease -- The Neuropathology of Huntingtonâ€{u3804}isease -- Neurobiology of Huntingtonâ€{u3804}isease -- Mouse Models of Huntingtonâ€{u3804}isease -- Transgenic Rat Models of Huntingtonâ€{u3804}isease -- Large Animal Models of Huntingtonâ€{u3804}isease -- Therapeutic Strategies for Huntingtonâ€{u3804}isease -- Clinical and Pathological Features of Parkinsonâ€{u3804}isease -- Symptomatic Models of Parkinsonâ€{u3804}isease and L-DOPA-Induced Dyskinesia in Non-human Primates -- Neuroinflammation in Parkinsonâ€{u3804}isease Animal Models: A Cell Stress Response or a Step in Neurodegeneration? -- Viral Vector-Based Models of Parkinsonâ€{u3804}isease -- Transgenic Rodent Models to Study Alpha-Synuclein Pathogenesis, with a Focus on Cognitive Deficits -- Modeling LRRK2 Pathobiology in Parkinsonâ€{u3804}isease: From Yeast to Rodents -- Models of Multiple System Atrophy.
520 _aMotor dysfunction and cognitive impairment are major symptoms in both Huntingtonâ€{u3804}isease (HD) and Parkinsonâ€{u3804}isease (PD). A breakthrough in HD research occurred in 1993, with the identification of the gene causing this devastating monogenetic illness. Since 1996, several genes were reported to cause familial forms of PD. Following these genetic discoveries, a variety of genetic disease models were generated, providing completely novel opportunities to explore the neurobiological basis of HD and PD. Genetic models allow us to study the earliest manifestations of the diseases both behaviorally and neuropathologically, and provide tools to probe molecular pathways of neurodegeneration. Additionally, neurotoxic animal models allow us to reproduce neurochemical and cellular events of great pathophysiological importance. In the PD field, neurotoxic animal models remain the preferred option to reproduce symptomatic features of the human disease that are responsive to dopaminergic pharmacotherapies. In addition, neurotoxic PD models are often used to investigate pathways of mitochondrial dysfunction, oxidative stress, and neuroinflammation. This book provides up-to-date reviews on current animal models of both HD and PD. These animal models are essential to investigate links between the pathobiology and the behavioral abnormalities associated with these disorders.
650 7 _aNeurología
_2embne
_9139040
650 7 _aParkinson, Enfermedad de
_2embne
_9141804
700 1 _aCenci, M. Angela
_eeditor literario
_994051
_0Local
_0http://id.loc.gov/authorities/names/nb2010024617
_1http://viaf.org/viaf/152711975
700 1 _aNguyen, Hoa Huu Phuc
_eeditor literario
_994050
_0Local
_0http://id.loc.gov/authorities/names/n2015189220
_1http://viaf.org/viaf/243144782712282545533
710 2 _aSpringerLink (Online service)
_0Local
_0http://id.loc.gov/authorities/names/no2005046756
_1http://viaf.org/viaf/148105729
_9106996
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-662-46344-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b1290157x
_b10-10-17
_c18-01-16
942 _2lcc
_cLE
945 _aRC321-580 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11571196
_z06-04-17
988 0 0 _aEBOOK, EBSPRINGER, GOBI_sep2018
988 _aEbook_one2one
998 _aSI
_a_alco
_a_vill
_b10/2018
_cm
_dz
_ef
_feng
_ggw
_h0
999 _c81567
_d81567
_x1